Related Experiment Video
Updated: Aug 5, 2025

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence
Published on: June 10, 2025
Future of Artificial Intelligence Applications in Cancer Care: A Global Cross-Sectional Survey of Researchers
Bernardo Pereira Cabral1, Luiza Amara Maciel Braga2, Shabbir Syed-Abdul3,4
1Department of Economics, Federal University of Bahia, Salvador 40060-300, Brazil.
Abstract:
Cancer significantly contributes to global mortality, with 9.3 million annual deaths. To alleviate this burden, the utilization of artificial intelligence (AI) applications has been proposed in various domains of oncology. However, the potential applications of AI and the barriers to its widespread adoption remain unclear. This study aimed to address this gap by conducting a cross-sectional, global, web-based survey of over 1000 AI and cancer researchers. The results indicated that most respondents believed AI would positively impact cancer grading and classification, follow-up services, and diagnostic accuracy. Despite these benefits, several limitations were identified, including difficulties incorporating AI into clinical practice and the lack of standardization in cancer health data. These limitations pose significant challenges, particularly regarding testing, validation, certification, and auditing AI algorithms and systems. The results of this study provide valuable insights for informed decision-making for stakeholders involved in AI and cancer research and development, including individual researchers and research funding agencies.
Insights
Artificial intelligence (AI) shows promise in improving cancer care, particularly in diagnosis and classification. However, challenges in clinical integration and data standardization hinder widespread adoption of AI in oncology.
Area of Science:
- Oncology
- Artificial Intelligence
- Medical Informatics
Background:
- Cancer remains a leading cause of global mortality, necessitating innovative solutions.
- Artificial intelligence (AI) presents potential applications across various oncology domains.
- Understanding AI's specific benefits and adoption barriers in cancer care is crucial.
Purpose of the Study:
- To investigate the perceived applications of AI in oncology.
- To identify the key barriers to the widespread adoption of AI in cancer research and clinical practice.
Main Methods:
- A global, cross-sectional, web-based survey was conducted.
- Over 1000 AI and cancer researchers participated in the survey.
Main Results:
- Most respondents anticipate positive impacts of AI on cancer grading, classification, follow-up services, and diagnostic accuracy.
- Significant barriers include challenges in clinical integration and lack of standardized cancer health data.
- Testing, validation, certification, and auditing of AI systems face considerable hurdles.
Conclusions:
- AI holds significant potential to advance cancer care, but practical implementation is complex.
- Addressing data standardization and clinical integration challenges is essential for realizing AI's full potential in oncology.
- Findings offer insights for researchers, developers, and funding agencies in AI-driven cancer research.
Related Concept Videos
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cancer Survival Analysis
Current Trends in Nursing II
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

